Learn more about our programs
Diversity in Clinical Trials

All Together Now for Cancer Clinical Trials: Meeting the Needs of Diverse Communities - A Focus on Lung Cancer

Available Monday, August 9 2021

Register Now

Produced in collaboration with LUNGevity and Stand Up To Cancer
Support for this patient education program was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. and Pfizer.

Have you ever considered participating in a clinical trial? Clinical trials allow cancer patients to be actively involved in their healthcare through new treatments and expert medical care. If you have cancer and participate in a clinical trial, you will get early access to life-saving therapies and contribute to the improvement of health care of diverse communities.

An under-representation of racial and ethnic minority groups in clinical trials has been, and continues to be, a major component of health care deficiencies in the US. To help you understand the critical role clinical trials play in treating cancer, along with the benefits to you and your care, a series of 15-minute modules will explore these issues using lung cancer as an example, but also touching on additional tumor types.

Please join us for a free, one-hour online educational module, “Diverse Cancer Communities: All Together Now for Cancer Clinical Trials – A Focus on Lung Cancer,” led by experts from the H. Lee Moffitt Cancer Center & Research Institute, beginning on August 9, 2021, to learn more about participating in clinical trials.

The program consists of 4 modules. Module 1 will cover “Clinical Trials: What they mean and Their Role in Care”; Module 2 will look at “The Patient Experience with Clinical Trials”; Module 3 will review next "Next Steps in Seeing if a Trial is Right for Me"; and the final Module, "Key Questions and Answers About Clinical Trials for Patients,”

After viewing this program you’ll be empowered to separate the facts from the myths about clinical trials. Your will also have a better understanding of:

  • Different types of research
  • Commonly used terminology
  • Roles of the different stakeholders including investigators, research coordinators, community leaders, and government agencies
  • The 4 phases of clinical trials
  • What questions to ask your doctor about participating in a clinical trial

In addition, you will learn about tools and cancer advocacy groups.

Register to watch on-demand August 9th



Jhanelle Gray, MD

Program Co-Leader, Molecular Medicine. Chair, Department of Thoracic Oncology Moffitt Cancer Center

Susan Vadaparampil, PhD, MPH

Senior Member and Associate Center Director of Community Outreach, Engagement, & Equity. Co-Program Director, Moffitt Behavioral Oncology Postdoctoral Training Program Moffit Cancer Center

Amit Tandon, MD

Assistant Professor of Medicine, Morsani College of Medicine, Division of Pulmonary and Critical Care Medicine University of South Florida Pulmonary/Critical Care and Interventional Pulmonology Specialist Thoracic Oncology Program Director, Interventional Pulmonology Program Moffitt Cancer Center

Ronald Hubbard

Lung Cancer Clinical Trial Patient

Lanse Scriven

Interview Participant - Cancer Clinical Trial Patient




  • lungevity logo
  • Stand Up To Cancer logo